Skip to content
Open access

Detection of potentially curable recurrence after colorectal cancer surgery in a real-world population

Oct 2026 · PLoS ONE · Vol 21, pp. e0361933 - e0361933 · 0 citations · 30 references
Medicine

TL;DR

Standard follow-up enabled the detection of potentially curable recurrence in 8% of CRC patients, and the substantial variation in NNFU across subgroups and the limited sensitivity of CEA underscore the need for more personalized, risk‑adapted surveillance strategies.

Abstract

Introduction After curative surgery for colorectal cancer (CRC), patients undergo surveillance because of the risk of recurrence; however, only a subset develops recurrence amenable to further curative-intent treatment. The primary aim of follow‑up is to identify patients with potentially curable recurrence. Materials and methods A retrospective analysis was performed of stage I–IV CRC patients who underwent curative-intent treatment and entered postoperative surveillance at Isala between 2014 and 2018. Follow‑up was conducted according to Dutch guideline‑based protocols for 60 months. Patients were categorized as having no recurrence, a potentially curable recurrence, or a non-curable recurrence. Prognostic factors at start of follow-up for potentially curable recurrence were assessed using competing‑risk Cox regression, with non-curable recurrence and death as competing events. For patients with recurrence, mode and time of detection were evaluated. Results During a median follow-up of 60 months, recurrence occurred in 22.4% of 1118 patients. The cumulative incidence function (CIF) of a potentially curable recurrence was 8.0%. Independent variables associated with a potentially curable recurrence were age HR 0.97 (95% CI 0.96–0.99), minor postoperative complications HR 1.78 (95% CI 1.16–2.72), stage III CRC HR2.76 (95% CI 1.19–6.38) and stage IV CRC HR 11.02 (95% CI 4.44–27.37). Among patients with a recurrence, CEA ≥ 5 ng/mL was present in 63% of all recurrences, but less often in the potentially curable group (57% vs. 69%, p = 0.057). Median time to detection of a potentially curable recurrence was 16 months (IQR 20). The overall number needed to follow-up (NNFU) to detect one potentially curable recurrence was 9.8, with the lowest NNFU observed in stage IV CRC (2.3) and in rectal cancer (6.9). Conclusion Standard follow-up enabled the detection of potentially curable recurrence in 8% of CRC patients. The substantial variation in NNFU across subgroups and the limited sensitivity of CEA underscore the need for more personalized, risk‑adapted surveillance strategies.

Read PDF

Similar papers

Open access Oct 2026

Risk factors for recurrence after initial transurethral resection of bladder tumor in patients with non–muscle-invasive bladder cancer

Background Recurrence remains common after initial transurethral resection of bladder tumor (TURBT) for non–muscle-invasive bladder cancer (NMIBC). This study aimed to identify routinely available clinicopathological, treatment-related, and inflammatory factors associated with recurrence and to characterize recurrence-...

F. Yuan, Xiong Li, Jing Zhang et al. · 0 citations
Open access Nov 2026

Curative Versus Non-Curative First Recurrence After Surgical Resection for Hepatocellular Carcinoma: Determinants, Patterns, and Clinical Impact.

BACKGROUND Recurrence after curative-intent resection for hepatocellular carcinoma (HCC) is common. Not all recurrences are clinically equivalent, as some remain amenable to curative treatment. AIMS This study aimed to evaluate the clinical impact of curatively versus noncuratively treatable first recurrence on postr...

A. Mantas, S. Lueong, Marlene Dropmann et al. · 0 citations
Oct 2026

Early Recurrence Limits Post-recurrence Therapy in Biliary Tract Cancer: A Rationale for Neoadjuvant Chemotherapy.

Patients with resectable BTC with elevated CA19-9 or clinical lymph node positivity are at high risk of early recurrence and limited treatment feasibility after recurrence, and NAC may improve outcomes in this population by delaying recurrence.

Daisaku Yamada, H. Akita, Y. Mukai et al. · 1 citation
Open access Nov 2026

A Dynamic Stratification Strategy for Assessing Postoperative Recurrence Risk in Colorectal Cancer

{'en': 'Objective: To investigate the value of a dynamic stratification strategy based on continuous updating at follow-up visits for predicting postoperative recurrence risk in colorectal cancer. Methods: A retrospective cohort of 596 patients with stage II–III colorectal cancer who underwent R0 curative resection bet...

Jin-Rong Zhang · 0 citations
Open access Oct 2026

Recurrence After Resection of Colorectal Liver Metastases and Its Impact on Survival: A Multistate Model-Based, Multi-institutional Observational Cohort Study.

BACKGROUND Conventional survival analyses cannot fully account for recurrence as an intermediate event that dynamically influences subsequent mortality. Multistate models (MSMs) enable explicit modeling of transitions between clinically relevant disease states; however, their application among patients undergoing resec...

A. Baldo, M. Akabane, C. Charalampous et al. · 1 citation
Nov 2026

Differences in Presentation and Prognosis of Early versus Late Diagnosis of Locoregional Recurrences after Colon Cancer Resection: A Nationwide Cohort Study.

BACKGROUND Despite advances in treatment of primary colon cancer, approximately 5 to 10% of patients will develop a locoregional recurrence of colon cancer. Early recurrences diagnosed within 1 year have been associated with worse outcomes, but evidence is limited and conflicting. OBJECTIVE This study aimed to evalua...

E. Rademaker, I. Hochstenbach, J. M. van der Woude et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.